Recommended content

Washington House Panel Amends Psilocybin Research Bill To Add Patient Access Provisions Back In

A House committee in Washington State has amended and approved a psilocybin bill—inserting some therapeutic access provisions back into the legislation after the Senate had stripped it down to focus on research only

The amendment, from Rep. Nicole Macri (D), was approved on a voice vote Wednesday by the House Health Care and Wellness Committee. The panel went on to approve the amended bill on a bipartisan 13–4 vote. Three of the panel’s seven Republican members, as well as all ten Democrats, ultimately supported the psilocybin measure.

“The bill as it stands takes very thoughtful steps towards a way that we as a state can consider a regulatory framework,” Macri said before the vote. “I like that the advisory group will come back with recommendations to the legislature next session and that, with this pilot that we have added to it, can gain more insight into the applicability of this service.”

“You know, this bill started out in the Senate in a far more ambitious way,” she added.

SB 5263 was originally introduced by Sen. Jesse Salomon (D) as a measure to allow adults to 21 and older to lawfully use psilocybin in a supervised setting. But those provisions were

Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment
Source

More news